Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Interest Expenses (2016 - 2025)

Immucell's Interest Expenses history spans 12 years, with the latest figure at $106145.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 22.06% year-over-year to $106145.0; the TTM value through Dec 2025 reached $240661.0, down 57.68%, while the annual FY2025 figure was $493384.0, 13.25% down from the prior year.
  • Interest Expenses reached $106145.0 in Q4 2025 per ICCC's latest filing, down from $134516.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $146003.0 in Q1 2024 to a low of $88577.0 in Q2 2023.
  • Average Interest Expenses over 3 years is $123493.5, with a median of $135356.0 recorded in 2024.
  • Peak YoY movement for Interest Expenses: soared 62.25% in 2024, then fell 22.06% in 2025.
  • A 3-year view of Interest Expenses shows it stood at $88577.0 in 2023, then surged by 53.76% to $136196.0 in 2024, then decreased by 22.06% to $106145.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Interest Expenses are $106145.0 (Q4 2025), $134516.0 (Q3 2025), and $136196.0 (Q4 2024).